AVN944

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Pancreatic CancerRefractory Solid Tumors

Phase 2

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

TerminatedNCT00493441

Vertex Pharmaceuticals IncorporatedPancreatic Cancer

Start: 2007-06-30End: 2009-12-31Updated: 2020-09-30

Unknown Phase

A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors

WithdrawnNCT00923728

Vertex Pharmaceuticals IncorporatedRefractory Solid Tumors

Start: 2009-04-30End: 2010-03-31Updated: 2014-01-10